Physician profile
Hannah E Katz
NPI 1356939201
$5,979.22
in general payments reported to CMS, 2019-2025
39 companies · $3,646 in 2025
The $3,646 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.19 · 2022: $444 · 2023: $697 · 2024: $1,178 · 2025: $3,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,718 · Travel and Lodging: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,717.95 |
| Travel and Lodging | $803.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,265.48 | 2024-2025 | Watchman Access System, Watchman Flx |
| Astrazeneca Pharmaceuticals Lp | $708.67 | 2022-2025 | Wainua, Fasenra, Xigduo |
| E.R. Squibb & Sons, L.L.C. | $437.46 | 2022-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $420.93 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.35 | 2022-2025 | Jardiance, Tradjenta, Synjardy |
| Novartis Pharmaceuticals Corporation | $381.97 | 2022-2025 | |
| Heartflow, INC. | $302.51 | 2025 | |
| Amgen INC. | $290.74 | 2022-2025 | Repatha, Tezspire, Repatha |
| Pfizer INC. | $188.16 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $168.05 | 2022-2025 | Dupixent |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.91 | 2023-2025 | Lifevest |
| Abiomed | $129.74 | 2025 | |
| Altathera Pharmaceuticals LLC | $129.01 | 2025 | Sotalol Hydrochloride |
| Abbott Laboratories | $124.92 | 2025 | Triclip |
| Bridgebio Pharma, INC. | $111.30 | 2025 | Attruby |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $98.54 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $74.44 | 2022-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $68.48 | 2021-2023 | Prolastin-C Liquid |
| Novo Nordisk INC | $62.20 | 2023-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $43.78 | 2024-2025 | Verquvo |
| Lilly USA, LLC | $42.80 | 2023-2024 | Jardiance, Zepbound |
| Lexicon Pharmaceuticals, INC. | $34.68 | 2023-2024 | Inpefa |
| Xeris Pharmaceuticals, INC. | $32.58 | 2023 | Gvoke Hypopen |
| Azurity Pharmaceuticals, INC. | $32.32 | 2024 | Edarbi |
| Janssen Pharmaceuticals, INC | $30.01 | 2023 | Xarelto |
| Glaxosmithkline, LLC. | $28.93 | 2023 | Shingrix, Arexvy |
| Impulse Dynamics (USA) INC. | $27.42 | 2022 | |
| Baxter Healthcare | $26.18 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Inspire Medical Systems, INC. | $21.96 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $21.33 | 2025 | Onpattro |
| Avadel Cns Pharmaceuticals, LLC | $20.04 | 2025 | Lumryz |
| Ultragenyx Pharmaceutical INC. | $19.13 | 2023 | |
| Edwards Lifesciences Corporation | $18.91 | 2024 | |
| Philips North America LLC | $18.38 | 2024 | (5044) Mcot |
| Harmony Biosciences LLC | $17.90 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $15.73 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $15.03 | 2024 | |
| Electromed, INC. | $14.74 | 2025 | Smartvest |
| Sumitomo Pharma America, INC. | $11.51 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.